While glutathione is approved for certain medical applications, its use for cosmetic enhancement remains off-label, placing responsibility on providers and patients to navigate potential risks without regulatory guidance
Liu N, Wu WL, Wan XR, Wang J, Huang JN, Jiang YY, et al
It will depend on the ability to connect multiple sources of evidence, including: Clinical trial data Real-world clinical data Patient-reported outcomes Biomarker and genomic information Healthcare utilization data Digital health technologies The goal is not to replace randomized clinical trials but to complement them, creating a more complete picture of how therapies perform in real-world healthcare settings
Despite the warning label, individuals continue to use them and the individual does not know what they are getting all the time. There is some research on the following peptide injections: Body Protection Compound-157 (BPC-157) Initial and pre-clinical-trial research suggest BPC-157 may promote musculoskeletal healing, which could explain its popularity among athletes (although it is banned in professional sports)